Cancer Clinical Trial
Official title:
Determinants of Multiple Health Risk Behaviors Among Latinos
The goal of this research study is to learn how cultural, environmental, and interpersonal experiences, as well as personal thoughts and feelings, influence cancer risk behaviors among Latino residents of Houston, Texas.
Study Participation:
If you are eligible and choose to take part in this study, you can choose to visit the clinic
2 times or have research staff visit you in your home or a community setting (such as a
church or community center) 2 times.
At the first visit (this is the same visit where you complete the in-person screening test):
- You will have your height, weight, and waistline measured.
- You will be given a smart phone to take home with you. You will answer questions on the
smart phone up to 5 times a day for 7 days. The phone will beep at random times (4 times
per day) and set times (in the evening) to prompt you to answer questions about what you
are doing and your current thoughts and feelings. These questions should take about 5-7
minutes to complete each time.
- You will be given an accelerometer (a movement meter). The accelerometer is a small
device worn on your hip that measures the amount of physical activity you do. You will
wear the accelerometer for 7 days in a row.
- You will receive training on how to use the smart phone and the accelerometer.
At the second visit, you will return the smart phone and the accelerometer.
At both study visits, you will be asked to complete questionnaires that ask about your
feelings, moods, and behaviors. You will complete 36 questionnaires at the first visit (a
total of 474 questions) and 25 questionnaires at the second visit (a total of 278 questions).
These questionnaires should take about 60 to 90 minutes to complete.
Throughout the study, you will be contacted by mail, email, or telephone for reminders of
visits. You will be reminded before each visit. You will be asked to provide the names and
contact information for family and/or friends should the study staff have trouble reaching
you.
Confidentiality:
Each time you complete a survey on the smart phone, your answers will be saved on the phone.
When you return the phone, all of your answers will be downloaded from the phone to a secure
server, where they will be stored. Then, all of your information will be deleted from the
phone. Your name or other personal information will not be stored on the phone.
Your name and other identifying information will not be stored together in the same files as
other information you provide during your participation in the study. The link between your
identifying information and other data will be kept in a separate file and securely
protected. The link between you and the study data will be destroyed 5 years after the study
ends.
Length of Study:
You will be considered off study when you complete the second visit.
This is an investigational study.
Up to 225 participants will take part in this study. All will be enrolled at MD Anderson.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|